Zsa Zsa Weerts

IBS symptoms and quality of life 65 3 24. Wiklund IK, Fullerton S, Hawkey CJ, et al. An irritable bowel syndrome-specific symptom questionnaire: development and validation, Scand J Gastroenterol. 2003; 38:947-954. 25. Labus JS, Bolus R, Chang L, et al. The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther. 2004;20: 89-97. 26. Diener E, Emmons RA, Larsen RJ, Griffin S. The satisfaction with life scale. J Pers Assess. 1985;49:71-75. 27. Pavot W, Diener E, Colvin CR, Sandvik E. Further validation of the Satisfaction with Life Scale: evidence for the cross-method convergence of well-being measures. J Pers Assess. 1991;57:149-161. 28. Van Beuningen J. Satisfaction With Life Scale: examining construct validity. Heerlen (The Hague), 2012. 29. Frandemark A, Tornblom H, Jakobsson S, Simren M. Work productivity and activity impairment in irritable bowel syndrome (IBS): a multifaceted problem. Am J Gastroenterol. 2018;113(10):1540-1549. 30. Bouwmans C, Krol M, Severens H, Koopmanschap M, Brouwer W, Hakkaart-van Roijen L. The iMTA productivity cost questionnaire: a standardized instrument for measuring and valuing health-related productivity losses. Value Health. 2015; 18:753-758. 31. Bouwmans C, Krol M, Brouwer W, Severens JL, Koopmanschap MA, Hakkaart L. IMTA productivity cost questionnaire (IPCQ), Value Health. 2014;17:A550. 32. Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing, 1995. 33. Weerts Z, Vork L, Mujagic Z, Keszthelyi D, Hesselink M, Jonkers D, Masclee A. The natural history of IBS: A five-year follow-up of the Maastricht IBS Cohort study, Poster Sessions, Poster 276. Neurogastroenterol Motil. 2018;30:1-186. 34. Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P. Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study. Aliment Pharmacol Ther. 2008; 28:1013-1020. 35. Mearin F, Badia X, Balboa A, et al. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients. Aliment Pharmacol Ther. 2006;23:815-826. 36. Card T, Enck P, Barbara G, et al. Post- infectious IBS: Defining its clinical features and prognosis using an internet-based survey. United European Gastroenterol J. 2018;6: 1245-1253. 37. Clevers E, Tack J, Tornblom H, et al. Development of irritable bowel syndrome features over a 5-year period. Clin Gastroenterol Hepatol. 2018;16(8). 38. Drossman DA, Patrick DL, Whitehead WE, et al. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol. 2000; 95:999. 39. Ware JE Jr, Gandek B, Kosinski M, et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International quality of life assessment. J Clin Epidemiol. 1998;51:1167- 1170. 40. Kanuri N, Cassell B, Bruce SE, et al. The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS). Neurogastroenterol Motil. 2016;28:1508- 1517. 41. Sarid O, Slonim-Nevo V, Pereg A, et al. Coping strategies, satisfaction with life, and quality of life in Crohn's disease: A gender perspective using structural equation modeling analysis. PloS One. 2017;12:e0172779. 42. Naliboff BD, Kim SE, Bolus R, Bernstein CN, Mayer EA, Chang L. Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: a structural equation modeling analysis. Am J Gastroenterol. 2012;107: 451-459. 43. Koloski NA, Boyce PM, Jones MP, Talley NJ. What level of IBS symptoms drives impairment in health-related quality of life in community subjects with irritable bowel syndrome? Qual Life Res. 2012;21:829-836. 44. Addante R, Naliboff B, Shih W, et al. Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals. J Clin Gastroenterol. 2018;53:e142-e149. 45. Max JS, lt sup, et al. What Is New in Rome IV. J Neurogastroenterol Motil. 2017;23:151-163. 46. Tornblom H, Drossman DA. Psychotropics, antidepressants, and visceral analgesics in